KRS
ALNY icon

Kentucky Retirement Systems’s Alnylam Pharmaceuticals ALNY Stock Holding History

Kentucky Retirement Systems’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Buy
+8,002
New +$2.41M 0.06% 263
2026
Q1 		– Sell
-7,836
Closed -$3.12M – 504
2025
Q4 		$3.12M Hold
7,836
– – 0.08% 209
2025
Q3 		$3.57M Sell
7,836
-417
-5% -$170K 0.1% 188
2025
Q2 		$2.69M Sell
8,253
-541
-6% -$150K 0.08% 236
2025
Q1 		$2.37M Buy
+8,794
New +$2.26M 0.07% 252

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kentucky Retirement Systems's ALNY Position: Q2 2026 in Review

Kentucky Retirement Systems opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 8,002 shares worth $2.41M. The stake represents 0.06% of the portfolio and ranks #263 among its holdings. This is a return to the name: Kentucky Retirement Systems previously reported a position in ALNY as recently as Q4 2025.

Kentucky Retirement Systems first reported a position in ALNY in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.57M in Q3 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Kentucky Retirement Systems held 8,002 shares of Alnylam Pharmaceuticals worth $2.41M as of Q2 2026.
  • Alnylam Pharmaceuticals was a new Kentucky Retirement Systems position in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.06% of Kentucky Retirement Systems's portfolio in Q2 2026, its #263 holding.
  • Kentucky Retirement Systems first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Kentucky Retirement Systems's Alnylam Pharmaceuticals position peaked at $3.57M in Q3 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Kentucky Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.